Nothing Special   »   [go: up one dir, main page]

HK1223624A1 - 替諾福韋的固體形式 - Google Patents

替諾福韋的固體形式

Info

Publication number
HK1223624A1
HK1223624A1 HK16111943.7A HK16111943A HK1223624A1 HK 1223624 A1 HK1223624 A1 HK 1223624A1 HK 16111943 A HK16111943 A HK 16111943A HK 1223624 A1 HK1223624 A1 HK 1223624A1
Authority
HK
Hong Kong
Prior art keywords
tenofovir
solid forms
solid
forms
Prior art date
Application number
HK16111943.7A
Other languages
English (en)
Inventor
‧赫爾利
‧拉皮納
石兵
王方
王智賢
‧沃
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1223624A1 publication Critical patent/HK1223624A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
HK16111943.7A 2014-01-15 2016-10-17 替諾福韋的固體形式 HK1223624A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927617P 2014-01-15 2014-01-15
PCT/US2015/010831 WO2015108780A1 (en) 2014-01-15 2015-01-09 Solid forms of tenofovir

Publications (1)

Publication Number Publication Date
HK1223624A1 true HK1223624A1 (zh) 2017-08-04

Family

ID=52434978

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111943.7A HK1223624A1 (zh) 2014-01-15 2016-10-17 替諾福韋的固體形式

Country Status (20)

Country Link
US (2) US9487546B2 (zh)
EP (1) EP3094637B1 (zh)
JP (2) JP2017507914A (zh)
KR (1) KR20160099655A (zh)
CN (1) CN105960409A (zh)
AR (1) AR099082A1 (zh)
AU (1) AU2015206758B2 (zh)
CA (1) CA2935965A1 (zh)
EA (1) EA031174B1 (zh)
ES (1) ES2762783T3 (zh)
HK (1) HK1223624A1 (zh)
IL (1) IL246569A0 (zh)
MX (1) MX2016008884A (zh)
NZ (1) NZ721832A (zh)
PL (1) PL3094637T3 (zh)
PT (1) PT3094637T (zh)
SG (1) SG11201605415RA (zh)
SI (1) SI3094637T1 (zh)
TW (1) TWI660965B (zh)
WO (1) WO2015108780A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7381190B2 (ja) 2014-12-26 2023-11-15 エモリー・ユニバーシテイ N4-ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
CN106380484A (zh) * 2016-08-29 2017-02-08 杭州百诚医药科技股份有限公司 一种替诺福韦艾拉酚胺的新晶型及其制备方法
CN118477088A (zh) 2017-12-07 2024-08-13 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
JP4033494B2 (ja) * 1996-07-26 2008-01-16 ギリヤド サイエンシーズ, インコーポレイテッド ヌクレオチドアナログ
US5922695A (en) 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US5935946A (en) 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
EP2682397B1 (en) * 2000-07-21 2017-04-19 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
AP2089A (en) 2003-01-14 2010-01-11 Gilead Sciences Inc Compositions and methods for combination antiviraltherapy
WO2008007392A2 (en) * 2006-07-12 2008-01-17 Matrix Laboratories Limited Process for the preparation of tenofovir
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
ZA201103820B (en) * 2010-12-13 2012-01-25 Laurus Labs Private Ltd Process for the preparation of tenofovir
BR112014003420B1 (pt) * 2011-08-16 2021-07-20 Gilead Sciences, Inc Hemifumarato de tenofovir alafenamida. composição, seus métodos de preparação e uso
CN117343101A (zh) 2011-10-07 2024-01-05 吉利德科学公司 制备抗病毒核苷酸类似物的方法
ES2627348T3 (es) * 2011-11-16 2017-07-27 Laurus Labs Private Limited Proceso para la preparación de Tenofovir
CN103374038B (zh) * 2012-04-11 2016-04-13 广州白云山医药集团股份有限公司白云山制药总厂 一种抗病毒药物的制备方法
CN102899367B (zh) * 2012-09-24 2014-04-30 常州大学 一种生物法和化学法结合合成泰诺福韦的方法
CN103641758B (zh) * 2013-11-19 2016-03-30 重庆紫光化工股份有限公司 廉价的高纯度的d,l-蛋氨酸的制备方法

Also Published As

Publication number Publication date
AR099082A1 (es) 2016-06-29
WO2015108780A1 (en) 2015-07-23
US20170056424A1 (en) 2017-03-02
AU2015206758A1 (en) 2016-07-21
JP2018030884A (ja) 2018-03-01
PT3094637T (pt) 2019-12-12
CN105960409A (zh) 2016-09-21
JP2017507914A (ja) 2017-03-23
KR20160099655A (ko) 2016-08-22
EA201691203A1 (ru) 2016-12-30
ES2762783T3 (es) 2020-05-25
CA2935965A1 (en) 2015-07-23
US9487546B2 (en) 2016-11-08
PL3094637T3 (pl) 2020-04-30
MX2016008884A (es) 2016-09-16
TW201609780A (zh) 2016-03-16
SI3094637T1 (sl) 2019-12-31
US20150197535A1 (en) 2015-07-16
EP3094637A1 (en) 2016-11-23
SG11201605415RA (en) 2016-07-28
NZ721832A (en) 2017-09-29
EP3094637B1 (en) 2019-10-16
IL246569A0 (en) 2016-08-31
AU2015206758B2 (en) 2017-11-30
EA031174B1 (ru) 2018-11-30
TWI660965B (zh) 2019-06-01

Similar Documents

Publication Publication Date Title
GB201413564D0 (en) Time of flight determination
IL257026A (en) Solid state forms of eluxadoline
GB2536295B (en) Forming of battery components
SI3154526T1 (sl) Trdne oblike sofosbuvira
IL246979A0 (en) Crystalline forms of sofosbuvir
GB201411526D0 (en) Powder
ZA201706282B (en) Solid forms of menaquinols
GB201410030D0 (en) Hydrophobic powder
HK1223624A1 (zh) 替諾福韋的固體形式
ZA201608686B (en) Interseparation of metals
GB201409620D0 (en) Range determination
IL249130A0 (en) Preparation of piperidine-4-carbthioamide
GB2550525B (en) Forming of battery components
GB201702149D0 (en) Chlorination of sucrose-6-esters
PT3131633T (pt) Derivados mmf de etilenogicois
GB2523810B (en) Component manufacture
IL249332A0 (en) Crystalline forms of sofosbuvir
GB201418230D0 (en) Construction of surfaces
GB201413139D0 (en) Assessment of structures
GB201413138D0 (en) Assessment of structures
TWM489582U (en) Improved structure of cup
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
GB201405155D0 (en) Theory of entertainment
GB201410184D0 (en) Odontalgic preparation